我要投票 海利在兽药行业中的票数:414
· 外 推 电 报 ·
2025-08-24 13:13:08 星期日

【海利是哪个国家的品牌?】

海利是什么牌子?「海利」是 上海海利生物技术股份有限公司 旗下著名品牌。该品牌发源于上海,由创始人张海明在1981期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海利品牌出海!将品牌入驻外推网,定制海利品牌推广信息,可以显著提高海利产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

上海海利生物技术股份有限公司(以下简称“海利生物”)位于上海奉贤经济开发区金海路6720号,其前身为上海松江生物药品厂,是农业部在上海批准生产兽用生物制品的定点企业及农业部在上海设立的动物重大疫情防治生产基地。作为一家专业的动物保健品公司,海利生物能够为预防动物疾病、改善动物福利和提高养殖业主的生产效益提供综合解决方案。海利生物的产品和服务涵盖了家畜、家禽以及宠物等多个领域。

海利生物是上海市高新技术企业、上海市农业产业化重点龙头企业、上海兽用生物制品工程技术研究中心、上海市科技小巨人(培育)企业;海利生物商标被认定为上海市著名商标,公司的疫苗产品荣获“上海名牌”称号;海利生物为上海农林职业技术学院(生物技术专业)的实习培训基地。

海利生物拥有11条GMP生产线,自主生产家畜、家禽两大系列共40多个产品。多年来,海利生物坚持科技创新之路,以市场为导向、以产品为依托,销售网络遍布全国,销售业绩成倍增长。海利生物现有员工近450名,其中专业技术人员占50%以上。海利生物坚持以人为本的人才战略,已建立起经营高效的管理团队、技术精湛的研发团队以及技能娴熟的员工团队。

在企业快速发展中,海利生物高度重视产、学、研相结合的产品战略,以市场为导向,几年来先后与国内行业领先的中国科学院、中国农科院哈尔滨兽医研究所、南京农业大学、河南农业大学等科研机构合作,共同开发具有国内外先进水平的兽用生物疫苗。特别是拥有了猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪圆环病毒2型灭活疫苗(LG株)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪链球菌二联灭活疫苗、鸡新城疫/传染性支气管炎/减蛋综合征/禽流感(H9N2)四联灭活疫苗等国家一、二类新药的知识产权,其中多个新产品的研发及产业化项目获得了上海市科委、上海市经委的科技创新项目立项支持。海利生物的猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪圆环病毒2型灭活疫苗、猪链球菌灭活疫苗、高致病性猪繁殖与呼吸综合征活疫苗已先后被认定为上海市科委高新技术成果转化项目,猪链球菌二联灭活疫苗荣获上海市科技进步二等奖。尤其从2007年开始,在全国范围内爆发的猪蓝耳病疫情防治工作中,海利生物承担了农业部定点生产高致病性猪蓝耳病疫苗的重要任务,为广大养殖户提供优质、可靠的疫苗,及时有效地防控了疫情的蔓延。

海利生物致力于为预防畜禽疾病、改善畜禽健康和提高养殖业主的生产效益服务,并能够提供综合解决方案和权威的兽医专家服务系统。为满足市场需求,海利生物一如既往地坚持自主创新及高新技术产业化发展的战略重点,力争跻身国内兽用生物疫苗行业前列。



英文翻译:Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as "Haili biology") is located at No. 6720, Jinhai Road, Fengxian Economic Development Zone, Shanghai. Its predecessor is Shanghai Songjiang biological medicine factory. It is a designated enterprise approved by the Ministry of agriculture to produce biological products for animal use in Shanghai and a production base for animal major epidemic prevention and control established by the Ministry of agriculture in Shanghai. As a professional animal health products company, Haili bio can provide comprehensive solutions for preventing animal diseases, improving animal welfare and improving the production efficiency of breeding owners. Haili's products and services cover livestock, poultry and pets. Haili biology is a high-tech enterprise in Shanghai, a key leading enterprise of agricultural industrialization in Shanghai, a research center of animal biological products engineering technology in Shanghai, and a small giant (cultivation) enterprise of science and technology in Shanghai. Haili biology trademark is recognized as a famous trademark in Shanghai, The company's vaccine products won the title of "Shanghai famous brand"; Haili biology is the practice training base of Shanghai Agricultural and Forestry Vocational Technical College (Biotechnology Major). Haili biological has 11 GMP production lines, and independently produces more than 40 products in two series of livestock and poultry. Over the years, Haili biology adheres to the road of scientific and technological innovation, is market-oriented and product-based, with its sales network all over the country, and its sales performance has multiplied. Haili biology has nearly 450 employees, of which more than 50% are professional technicians. Haili biology adheres to the human-oriented talent strategy and has established an efficient management team, a skilled R & D team and a skilled staff team. In the rapid development of the enterprise, Haili biology attaches great importance to the product strategy of combining production, learning and research, and is market-oriented. In recent years, Haili biology has cooperated with Chinese Academy of Sciences, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Nanjing Agricultural University, Henan Agricultural University and other scientific research institutions to jointly develop animal biological vaccines with advanced level at home and abroad. In particular, it has the knowledge production of the first and second class new drugs in China, such as the live vaccine of porcine reproductive and respiratory syndrome (i.e. the live vaccine of blue ear disease), the inactivated vaccine of porcine circovirus type 2 (LG strain), the inactivated vaccine of swine infectious gastroenteritis and epidemic diarrhea, the inactivated vaccine of Streptococcus suis, the inactivated vaccine of Newcastle disease / infectious bronchitis / egg drop syndrome / avian influenza (H9N2), etc Among them, R & D and industrialization projects of many new products have been supported by science and technology innovation projects of Shanghai Municipal Commission of science and technology and Shanghai Economic Commission. Haili bio's live vaccine for porcine reproductive and respiratory syndrome (i.e. live vaccine for blue ear disease), bivalent inactivated vaccine for transmissible gastroenteritis and epidemic diarrhea, bivalent inactivated vaccine for porcine circovirus type 2, Streptococcus suis, and highly pathogenic live vaccine for porcine reproductive and respiratory syndrome have been successively recognized as the high-tech achievement transformation project of Shanghai Science and Technology Commission, bivalent inactivated vaccine for Streptococcus suis Won the second prize of Shanghai Science and technology progress award. Especially since 2007, in the prevention and control of the outbreak of blue ear disease nationwide, Haili biology has undertaken the important task of producing highly pathogenic blue ear disease vaccine designated by the Ministry of agriculture, providing high-quality and reliable vaccine for the majority of farmers, and preventing and controlling the spread of the disease in time and effectively. Haili biology is committed to the prevention of livestock and poultry diseases, improve the health of livestock and poultry and improve the production efficiency of breeding owners, and can provide comprehensive solutions and authoritative veterinary expert service system. In order to meet the market demand, Haili biology, as always, adheres to the strategic focus of independent innovation and the development of high-tech industrialization, and strives to be in the forefront of domestic veterinary biological vaccine industry.

本文链接: https://www.waitui.com/brand/5c9756dfe.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

澳大利亚将加快住房建设以应对持续危机

澳大利亚政府正计划推出一系列措施以加快房屋建设,因为该国仍在努力应对一场持续多年的全国性住房危机。根据周六的一份声明,政府将立即采取的措施包括加快对超过 26000 套新住宅的评估,并暂停进一步修改建筑法规以加快房屋审批。政府计划利用人工智能来帮助实施这些变革。住房部长克莱尔·奥尼尔在声明中表示:“在这个国家建房太难了。在一场持续数十年的住房危机中,我们希望建筑商能建造未来高品质的住宅,而不是琢磨如何应对又一套规则。”(新浪财经)

2小时前

央行公开市场下周将有20770亿元逆回购到期

Wind数据显示,下周央行公开市场将有20770亿元逆回购到期,其中下周一至下周五分别到期2665亿元、5803亿元、6160亿元、2530亿元、3612亿元。此外,下周二将有3000亿元MLF到期,下周五将有5000亿元6个月期买断式逆回购到期、4000亿元3个月期买断式逆回购到期。(证券时报)

2小时前

英国央行行长贝利:英国面临提高潜在增长率的挑战

英国央行行长安德鲁・贝利表示,只要劳动力参与率持续低迷,英国提高经济潜在增长率就将面临 “严峻挑战”。贝利在怀俄明州美联储杰克逊霍尔年会上对各国央行官员表示,英国劳动力市场的问题已不再是失业,而是劳动力参与率。除非更多英国人重新加入劳动力市场,否则必须 “更加强调生产率增长” 以提振经济。(新浪财经)

2小时前

可口可乐据悉考虑出售旗下英国咖啡连锁店Costa

据知情人士称,可口可乐已聘请投行帮助评估出售旗下英国咖啡连锁店Costa Coffee的可能性。这家总部位于亚特兰大的软饮料巨头已要求投行Lazard评估选项并评估对其2018年以39亿英镑(53亿美元)收购的这项业务的兴趣。据悉,可口可乐已与包括私募股权公司在内的少数潜在竞标者进行了初步接洽。消息人士称,目前不能确保达成交易,可口可乐最终仍可能决定不进行出售。(新浪财经)

2小时前

今年前7个月我国机械工业保持增长态势

记者从中国机械工业联合会获悉,今年以来,我国机械工业生产及投资保持增长态势。最新数据显示,今年1至7月份,机械工业主要涉及的五个大类行业增加值同比保持增长趋势。通用设备制造业增长8.3%;专用设备制造业增长3.8%;汽车制造业增长10.9%;电气机械和器材制造业增长11.9%;仪器仪表制造业增长7.1%。(央视新闻)

2小时前

本页详细列出关于海利的品牌信息,含品牌所属公司介绍,海利所处行业的品牌地位及优势。
咨询